Company profile

ariadne.ai ag company profile

ariadne.ai ag is a technology leader in high-throughput image analysis and spatial omics data interpretation, accelerating drug discovery with a particular focus on neurodegenerative diseases such as Alzheimer’s and Parkinson’s. As a software-based Contract Research Organization (CRO), we offer advanced, AI-driven solutions for extracting meaningful biological insights from a wide range of microscopy data—including confocal, brightfield, and electron microscopy—as well as from spatial omics experiments. Our expertise spans: Automated, scalable image analysis across all major microscopy platforms, enabling reproducible quantification for immunohistochemistry, high-content screening, and 3D tissue models. Spatial omics analytics for biomarker discovery and disease characterization, including spatial transcriptomics..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected].
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2014-01-01

Headquarters

Headquarters
Buchrain, Luzern, Switzerland
Postal code
6033
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $2.4M / 2022-03-29
Investors
1
Lead investors
1
Founders
3

Founders and investors

Founders

Adrian WannerDr. Jörgen KornfeldFabian Svara

Lead investors

European Innovation Council

Investors

European Innovation Council

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.